EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients

Marianna Talia, Eugenio Cesario, Francesca Cirillo, Domenica Scordamaglia, Marika Di Dio, Azzurra Zicarelli, Adelina Assunta Mondino, Maria Antonietta Occhiuzzi, Ernestina Marianna De Francesco, Antonino Belfiore, Anna Maria Miglietta, Michele Di Dio und 3 weitere

Journal of Translational Medicine · 2024

DOI: 10.1186/s12967-024-05413-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Translational Medicine, 2024. Verfasst von Marianna Talia und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, 87036, Italy. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Breast Neoplasms, Cancer-Associated Fibroblasts, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione AIRC per la ricerca sul cancro ETS, Ministero della Salute, Ministero dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Over the last two decades, tumor-derived RNA expression signatures have been developed for the two most commonly diagnosed tumors worldwide, namely prostate and breast tumors, in order to improve both outcome prediction and treatment decision-making. In this context, molecular signatures gained by main components of the tumor microenvironment, such as cancer-associated fibroblasts (CAFs), have been explored as prognostic and therapeutic tools. Nevertheless, a deeper understanding of the significance of CAFs-related gene signatures in breast and prostate cancers still remains to be disclosed.

Methods

RNA sequencing technology (RNA-seq) was employed to profile and compare the transcriptome of CAFs isolated from patients affected by breast and prostate tumors. The differentially expressed genes (DEGs) characterizing breast and prostate CAFs were intersected with data from public datasets derived from bulk RNA-seq profiles of breast and prostate tumor patients. Pathway enrichment analyses allowed us to appreciate the biological significance of the DEGs. K-means clustering was applied to construct CAFs-related gene signatures specific for breast and prostate cancer and to stratify independent cohorts of patients into high and low gene expression clusters. Kaplan-Meier survival curves and log-rank tests were employed to predict differences in the outcome parameters of the clusters of patients. Decision-tree analysis was used to validate the clustering results and boosting calculations were then employed to improve the results obtained by the decision-tree algorithm.

Results

Data obtained in breast CAFs allowed us to assess a signature that includes 8 genes ( ITGA11 , THBS1 , FN1 , EMP1 , ITGA2 , FYN , SPP1 , and EMP2 ) belonging to pro-metastatic signaling routes, such as the focal adhesion pathway. Survival analyses indicated that the cluster of breast cancer patients showing a high expression of the aforementioned genes displays worse clinical outcomes. Next, we identified a prostate CAFs-related signature that includes 11 genes ( IL13RA2 , GDF7 , IL33 , CXCL1 , TNFRSF19 , CXCL6 , LIFR , CXCL5 , IL7 , TSLP , and TNFSF15 ) associated with immune responses. A low expression of these genes was predictive of poor survival rates in prostate cancer patients. The results obtained were significantly validated through a two-step approach, based on unsupervised (clustering) and supervised (classification) learning techniques, showing a high prediction accuracy (≥ 90%) in independent RNA-seq cohorts.

Conclusion

We identified a huge heterogeneity in the transcriptional profile of CAFs derived from breast and prostate tumors. Of note, the two novel CAFs-related gene signatures might be considered as reliable prognostic indicators and valuable biomarkers for a better management of breast and prostate cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBreast NeoplasmsCancer-Associated FibroblastsGene Expression Regulation, NeoplasticHumansMaleFemalePrognosisTranscriptomeGene Expression ProfilingCluster AnalysisTreatment OutcomeMiddle AgedKaplan-Meier Estimate

Stichwörter der Autor:innen

Breast cancerCancer-associated fibroblasts (CAFs)Gene signatureK-means algorithmProstate cancer

Autor:innen und Institutionen

  • Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, 87036, Italy.
  • Department of Cultures, Education and Society, University of Calabria, Rende, 87036, Italy.
  • Department of Medicine and Surgery, University of Enna "Kore", Enna, 94100, Italy.
  • Endocrinology, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Hospital, Catania, 95122, Italy.
  • Breast and General Surgery Unit, Annunziata Hospital Cosenza, Cosenza, 87100, Italy.
  • Division of Urology, Department of Surgery, Annunziata Hospital, Cosenza, 87100, Italy.

Förderung

  • Fondazione AIRC per la ricerca sul cancro ETS
  • Ministero della Salute
  • Ministero dell'Università e della Ricerca
  • Ministero dell’Università e della Ricerca

Zitieren

APA

Talia, M., Cesario, E., Cirillo, F., Scordamaglia, D., Di Dio, M., Zicarelli, A., Mondino, A. A., Occhiuzzi, M. A., De Francesco, E. M., Belfiore, A., Miglietta, A. M., Di Dio, M., Capalbo, C., Maggiolini, M., & Lappano, R. (2024). Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients. Journal of Translational Medicine. https://doi.org/10.1186/s12967-024-05413-2

Vancouver

Talia M, Cesario E, Cirillo F, Scordamaglia D, Di Dio M, Zicarelli A, et al. Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients. Journal of Translational Medicine. 2024. doi:10.1186/s12967-024-05413-2

BibTeX
@article{Talia2024,
  author = {Talia, Marianna and Cesario, Eugenio and Cirillo, Francesca and Scordamaglia, Domenica and Di Dio, Marika and Zicarelli, Azzurra and Mondino, Adelina Assunta and Occhiuzzi, Maria Antonietta and De Francesco, Ernestina Marianna and Belfiore, Antonino and Miglietta, Anna Maria and Di Dio, Michele and Capalbo, Carlo and Maggiolini, Marcello and Lappano, Rosamaria},
  title = {Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients},
  journal = {Journal of Translational Medicine},
  year = {2024},
  doi = {10.1186/s12967-024-05413-2}
}
Kostenlos starten →